Mojo Vision doubles VC funding to $44M
Developer of micro-LED technology boosts series A venture round following pivot away from smart contact lenses.
Source: optics.org
📰 Advantech Capital News
Advantech Capital News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Advantech Capital. Real-time updates on events, politics, business and more.
Mojo Vision almost doubles Series A funding round to $43.5m
Funding to drive micro-LED development and commercialization
Source: semiconductor-today.com
Mojo Vision Closes $43.5M Series A Funding Round
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
SINOVAC Reports Unaudited First Half of 2023 Financial Results
Sinovac Biotech Ltd. , a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the six months ended June 30, 2023. First Half of 2023... -Today at 06:03 am- MarketScreener
Source: marketscreener.com
China's DataGrand nets $92m in Series C from CITIC, Shenzhen Capital, others
In 2020, DataGrand had secured $42m in a Series B+ round of financing from Shenzhen Capital, Z Capital, Chenshan Capital, and SAIF Partners.
Xiang He Yunwen Chen Oriza Holding Prior Fudan University China Construction Bank China Merchants Securities
Source: dealstreetasia.com
China Tech Digest: China's 'Sky Eye' FAST Detects About 500 New Pulsars; Chinese Residents Can Order Food Deliveries In Digital RMB – China Money Network
China’s ‘Sky Eye’ FAST detects about 500 new pulsars The Chinese Academy of Sciences recently held a press conference to unveil the operation conditions ... Beijing, Blue Ocean Capital Group, Oriza, Shanghai, shenzhen
Source: chinamoneynetwork.com
China's Innoforce Pharma raises $157m Series A funding
The company had raised 170 million yuan ($24 million) in a Pre-A funding round in June last year.
United States Yuling Li Everbright Secutie Innoforce Pharmaceuticals Peking University Backed Yanchuang Capital South China Venture Capital
Source: dealstreetasia.com
Ablaze Pharmaceuticals Raises $75M in Series A Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
US-China firm Ablaze Pharma nets $75m co-led by Vivo Capital
The fresh round was jointly led by AdvanTech Capital and Vivo Capital, a Palo Alto-based investment firm that backs the US and China healthcare market.
Source: dealstreetasia.com
Ablaze Pharmaceuticals Launches with $75m Series A Financing to Bring Novel Targeted Radiopharmaceuticals to Treat Cancer Patients in the Greater China Market
/PRNewswire/ -- Ablaze Pharmaceuticals ("Ablaze"), a clinical-stage pharmaceutical company focused on the development and commercialization of innovative...
Source: prnewswire.com